WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade

Background and purpose: Angiogenesis and lymphangiogenesis are major routes for metastatic spread of tumor cells. It thus represent the rational targets for therapeutic intervention of cancer. Recently, we showed that a novel aliphatic hydroxamate-based compound, WMJ-S-001, exhibits anti-angiogenic,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Huang, Shiu-Wen, Yang, Hung-Yu, Huang, Wei-Jan, Chen, Wei-Chuan, Yu, Meng-Chieh, Wang, Shih-Wei, Hsu, Ya-Fen, Hsu, Ming-Jen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6851263/
https://ncbi.nlm.nih.gov/pubmed/31781495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01188
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados